{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:38:35Z","timestamp":1780533515736,"version":"3.54.1"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T00:00:00Z","timestamp":1178928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T00:00:00Z","timestamp":1178928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00403-007-0744-y","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T08:17:57Z","timestamp":1178871477000},"page":"111-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)"],"prefix":"10.1007","volume":"299","author":[{"given":"A.","family":"Nast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. B.","family":"Banditt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Boehncke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kreiselmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mrowietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Ockenfels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. D.","family":"Orzechowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rosumeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schmid-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Weberschock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rzany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,12]]},"reference":[{"issue":"4","key":"744_CR1","first-page":"581","volume":"41","author":"HL Richards","year":"1999","unstructured":"Richards HL, Fortune DG, O\u2019Sullivan TM, Main CJ, Griffiths CE (1999) Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 41(4):581\u2013583","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"744_CR2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.1996.tb03826.x","volume":"135","author":"GJ Nevitt","year":"1996","unstructured":"Nevitt GJ, Hutchinson PE (1996) Psoriasis in the community: prevalence, severity and patients\u2019 beliefs and attitudes towards the disease. Br J Dermatol 135(4):533\u2013537","journal-title":"Br J Dermatol"},{"issue":"5","key":"744_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00105-005-0906-9","volume":"56","author":"G Schmid-Ott","year":"2005","unstructured":"Schmid-Ott G, Malewski P, Kreiselmaier I, Mrowietz U (2005) Psychosoziale Folgen der Psoriasis\u2014eine empirische Studie \u00fcber die Krankheitslast bei 3753 Betroffenen. Hautarzt 56(5):466\u2013472","journal-title":"Hautarzt"},{"issue":"3 Pt 1","key":"744_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41(3 Pt 1): 401\u2013407","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"744_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","volume":"9","author":"RS Stern","year":"2004","unstructured":"Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 9(2):136\u2013139","journal-title":"J Invest Dermatol Symp Proc"},{"issue":"1","key":"744_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.141.1.43","volume":"141","author":"CL Carroll","year":"2005","unstructured":"Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR (2005) Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol 141(1):43\u201346","journal-title":"Arch Dermatol"},{"issue":"8","key":"744_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1346-8138.2002.tb00321.x","volume":"29","author":"R Agarwal","year":"2002","unstructured":"Agarwal R, Saraswat A, Kaur I, Katare OP, Kumar B (2002) A novel liposomal formulation of dithranol for psoriasis: preliminary results. J Dermatol 29(8):529\u2013532","journal-title":"J Dermatol"},{"issue":"4","key":"744_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000065971","volume":"15","author":"A Monastirli","year":"2002","unstructured":"Monastirli A, Georgiou S, Pasmatzi E, Sakkis T, Badavanis G, Drainas D, Sagriotis A, Tsambaos D (2002) Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. Skin Pharmacol Appl Skin Physiol 15(4):246\u2013251","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"3","key":"744_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000029819","volume":"11","author":"MJ Gerritsen","year":"1998","unstructured":"Gerritsen MJ, Boezeman JB, Elbers ME, van de Kerkhof PC (1998) Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): a new approach in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 11(3):133\u2013139","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"3","key":"744_CR10","first-page":"214","volume":"11","author":"M Prins","year":"2001","unstructured":"Prins M, Swinkels OQ, Van de Kerkhof PC, Van der Valk PG (2001) The impact of the frequency of short contact dithranol treatment. Eur J Dermatol 11(3):214\u2013218","journal-title":"Eur J Dermatol"},{"key":"744_CR11","first-page":"28","volume":"172","author":"P Thune","year":"1992","unstructured":"Thune P, Brolund L (1992) Short- and long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis. Acta Derm Venereol Suppl 172:28\u201329","journal-title":"Acta Derm Venereol Suppl"},{"issue":"4","key":"744_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000210784","volume":"1","author":"S De Mare","year":"1988","unstructured":"De Mare S, Calis N, den Hartog G, van Erp PE, van de Kerkhof PC (1988) The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol 1(4):259\u2013264","journal-title":"Skin Pharmacol"},{"issue":"5","key":"744_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000029933","volume":"13","author":"M Prins","year":"2000","unstructured":"Prins M, Swinkels OQ, Bouwhuis S, de Gast MJ, Bouwman-Boer Y, van der Valk PG, van de Kerkhof PC (2000) Dithranol in a cream preparation: disperse or dissolve? Skin Pharmacol Appl Skin Physiol 13(5):273\u2013279","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"2","key":"744_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000018457","volume":"201","author":"PE Hutchinson","year":"2000","unstructured":"Hutchinson PE, Marks R, White J (2000) The efficacy, safety and tolerance of calcitriol 3 microg\/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. Dermatology 201(2):139\u2013145","journal-title":"Dermatology"},{"issue":"3","key":"744_CR15","first-page":"282","volume":"65","author":"G Mahrle","year":"1990","unstructured":"Mahrle G, Schulze HJ (1990) The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis. Z Hautkr 65(3):282, 285\u2013287","journal-title":"Z Hautkr"},{"issue":"5","key":"744_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1742-1241.1985.tb07812.x","volume":"39","author":"G Agrup","year":"1985","unstructured":"Agrup G, Agdell J (1985) A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis. Br J Clin Pract 39(5):185\u2013187","journal-title":"Br J Clin Pract"},{"issue":"4","key":"744_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2133.2002.04698.x","volume":"146","author":"OQ Swinkels","year":"2002","unstructured":"Swinkels OQ, Prins M, Kucharekova M, de Boo T, Gerritsen MJ, van der Valk PG, van de Kerkhof PC (2002) Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Br J Dermatol 146(4):621\u2013626","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10227-002-0114-5","volume":"7","author":"AB Gottlieb","year":"2003","unstructured":"Gottlieb AB, Ford R, Spellman MC (2003) The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg 7(3):185\u2013192","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"744_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/09546639109086777","volume":"2","author":"TY Chuang","year":"1991","unstructured":"Chuang TY, Samson CR (1991) Clinical efficacy and safety of augmented betamethasone dipropionate ointment and diflorasone ointment for psoriasis\u2014a multicentre, randomized, double-blinded study. J Dermatol Treat 2(2):63\u201366","journal-title":"J Dermatol Treat"},{"issue":"3","key":"744_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/09546639809160546","volume":"9","author":"HI Katz","year":"1998","unstructured":"Katz HI, Tanner DJ, Cuffie CA, Brody NI, Garcia CJ, Lowe NJ, Medansky RS, Roth HL, Shavin JS, Swinyer LJ (1998) A comparison of the efficacy and saftey of the combination mometasone furoate 0,1%\/salicylic acid 5% ointment with each of its components in psoriasis. J Dermatol Treat 9(3):151\u2013156","journal-title":"J Dermatol Treat"},{"issue":"2","key":"744_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0149-2918(98)80091-X","volume":"20","author":"J Koo","year":"1998","unstructured":"Koo J, Cuffie CA, Tanner DJ, Bressinck R, Cornell RC, DeVillez RL, Edwards L, Breneman DL, Piacquadio DJ, Guzzo CA, Monroe EW (1998) Mometasone furoate 0.1%\u2013salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study. Clin Ther 20(2):283\u2013291","journal-title":"Clin Ther"},{"issue":"1","key":"744_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09546630305545","volume":"14","author":"JM Camarasa","year":"2003","unstructured":"Camarasa JM, Ortonne JP, Dubertret L (2003) Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. J Dermatol Treat 14(1):8\u201313","journal-title":"J Dermatol Treat"},{"issue":"1","key":"744_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","volume":"48","author":"KA Papp","year":"2003","unstructured":"Papp KA, Guenther L, Boyden B, Larsen FG, Harvima RJ, Guilhou JJ, Kaufmann R, Rogers S, van de Kerkhof PC, Hanssen LI, Tegner E, Burg G, Talbot D, Chu A (2003) Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 48(1):48\u201354","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"744_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","volume":"82","author":"WS Douglas","year":"2002","unstructured":"Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ (2002) A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 82(2):131\u2013135","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"744_CR25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","volume":"205","author":"R Kaufmann","year":"2002","unstructured":"Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, Stymne B (2002) A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 205(4):389\u2013393","journal-title":"Dermatology"},{"issue":"4","key":"744_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10227-001-0006-0","volume":"5","author":"LF Stein","year":"2001","unstructured":"Stein LF, Sherr A, Solodkina G, Gottlieb AB, Chaudhari U (2001) Betamethasone valerate foam for treatment of nonscalp psoriasis. J Cutan Med Surg 5(4):303\u2013307","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"744_CR27","first-page":"201","volume":"74","author":"J Decroix","year":"2004","unstructured":"Decroix J, Pres H, Tsankov N, Poncet M, Arsonnaud S (2004) Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis. Cutis 74(3):201\u2013206","journal-title":"Cutis"},{"issue":"5","key":"744_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-4362.2002.01431.x","volume":"41","author":"M Lebwohl","year":"2002","unstructured":"Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR (2002) A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 41(5):269\u2013274","journal-title":"Int J Dermatol"},{"issue":"4","key":"744_CR29","first-page":"223","volume":"8","author":"V Peharda","year":"2000","unstructured":"Peharda V, Gruber F, Prpic L, Kastelan M, Brajac I (2000) Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0.05% ointment in the treatment of psoriasis vulgaris. Acta Derm Venereol Croat 8(4):223\u2013226","journal-title":"Acta Derm Venereol Croat"},{"issue":"2","key":"744_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000247323","volume":"186","author":"JL Shupack","year":"1993","unstructured":"Shupack JL, Jondreau L, Kenny C, Stiller MJ (1993) Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis. Dermatology 186(2):129\u2013132","journal-title":"Dermatology"},{"issue":"3","key":"744_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0011-393X(05)80413-8","volume":"52","author":"ARI Svensson","year":"1992","unstructured":"Svensson ARI, Gisslen H, Nordin P, Gios I (1992) A comperative study of mometasone furoate oinment and betamethasone valerate ointment in patients with Psoriasis vulgaris. Curr Ther Res Clin Exp 52(3):390\u2013396","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"744_CR32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1523-1747.ep12461062","volume":"90","author":"WL Weston","year":"1988","unstructured":"Weston WL, Fennessey PV, Morelli J, Schwab H, Mooney J, Samson C, Huff L, Harrison LM, Gotlin R (1988) Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol 90(4):532\u2013535","journal-title":"J Invest Dermatol"},{"issue":"4","key":"744_CR33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0149-2918(97)80094-X","volume":"19","author":"RS Medansky","year":"1997","unstructured":"Medansky RS, Cuffie CA, Tanner DJ (1997) Mometasone furoate 0.1%\u2013salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis. Clin Ther 19(4):701\u2013709","journal-title":"Clin Ther"},{"issue":"1","key":"744_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1067\/mjd.2003.417","volume":"49","author":"TS Housman","year":"2003","unstructured":"Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB Jr, Feldman SR (2003) The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol 49(1):79\u201382","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR35","first-page":"291","volume":"5","author":"F Bagatell","year":"1988","unstructured":"Bagatell F (1988) Management of psoriasis: a clinical evaluation of the dermatological patch, Actidermregistered trade mark, over a topical steroid. Adv Ther 5(6):291\u2013296","journal-title":"Adv Ther"},{"issue":"Suppl 1","key":"744_CR36","first-page":"26","volume":"11","author":"H Fabry","year":"1983","unstructured":"Fabry H, Yawalkar SJ (1983) A comparative multicentre trial of halometasone ointment and fluocortolone plus fluocortolone caproate ointment in the treatment of psoriasis. J Int Med Res 11(Suppl 1):26\u201330","journal-title":"J Int Med Res"},{"issue":"5","key":"744_CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1982.01650170033018","volume":"118","author":"DV Belsito","year":"1982","unstructured":"Belsito DV, Kechijian P (1982) The role of tar in Goeckerman therapy. Arch Dermatol 118(5): 319\u2013321","journal-title":"Arch Dermatol"},{"issue":"3","key":"744_CR38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0190-9622(84)70188-5","volume":"11","author":"KM Diette","year":"1984","unstructured":"Diette KM, Momtaz K, Stern RS, Arndt KA, Parrish JA (1984) Role of ultraviolet A in phototherapy for psoriasis. J Am Acad Dermatol 11(3):441\u2013447","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"744_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/1523-1747.ep12506317","volume":"78","author":"MJ LeVine","year":"1982","unstructured":"LeVine MJ, Parrish JA (1982) The effect of topical fluocinonide ointment on phototherapy of psoriasis. J Invest Dermatol 78(2):157\u2013159","journal-title":"J Invest Dermatol"},{"issue":"7","key":"744_CR40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archderm.1979.04010070016013","volume":"115","author":"P Frost","year":"1979","unstructured":"Frost P, Horwitz SN, Caputo RV, Berger SM (1979) Tar gel-phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol 115(7):840\u2013846","journal-title":"Arch Dermatol"},{"issue":"5","key":"744_CR41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2003.103","volume":"48","author":"GD Weinstein","year":"2003","unstructured":"Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS (2003) Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol 48(5):760\u2013767","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 54","key":"744_CR42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2133.1999.140S54018.x","volume":"140","author":"H Gollnick","year":"1999","unstructured":"Gollnick H, Menter A (1999) Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol 140(Suppl 54):18\u201323","journal-title":"Br J Dermatol"},{"issue":"2","key":"744_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10227-001-0031-z","volume":"6","author":"L Green","year":"2002","unstructured":"Green L, Sadoff W (2002) A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis. J Cutan Med Surg 6(2):95\u2013102","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"744_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-4362.2001.01167.x","volume":"40","author":"JY Koo","year":"2001","unstructured":"Koo JY, Martin D (2001) Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis. Int J Dermatol 40(3):210\u2013212","journal-title":"Int J Dermatol"},{"issue":"2 Pt 3","key":"744_CR45","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1067\/mjd.2000.108319","volume":"43","author":"M Lebwohl","year":"2000","unstructured":"Lebwohl M (2000) Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid. J Am Acad Dermatol 43(2 Pt 3):S43\u2013S46","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"744_CR46","first-page":"41","volume":"63","author":"YP Poulin","year":"1999","unstructured":"Poulin YP (1999) Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study. Cutis 63(1):41\u201348","journal-title":"Cutis"},{"issue":"3","key":"744_CR47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000057884","volume":"204","author":"PC Van de Kerkhof","year":"2002","unstructured":"Van de Kerkhof PC, Green C, Hamberg KJ, Hutchinson PE, Jensen JK, Kidson P, Kragballe K, Larsen FG, Munro CS, Tillman DM (2002) Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. Dermatology 204(3):214\u2013221","journal-title":"Dermatology"},{"issue":"2","key":"744_CR48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2133.2002.04967.x","volume":"147","author":"L Guenther","year":"2002","unstructured":"Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, Garcia-Diez A, Springborg J (2002) Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 147(2):316\u2013323","journal-title":"Br J Dermatol"},{"issue":"6","key":"744_CR49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2133.2004.05986.x","volume":"150","author":"K Kragballe","year":"2004","unstructured":"Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM (2004) Efficacy of once-daily treatment regimens with calcipotriol\/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 150(6):1167\u20131173","journal-title":"Br J Dermatol"},{"issue":"4","key":"744_CR50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000080854","volume":"209","author":"JP Ortonne","year":"2004","unstructured":"Ortonne JP, Kaufmann R, Lecha M, Goodfield M (2004) Efficacy of treatment with calcipotriol\/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology 209(4):308\u2013313","journal-title":"Dermatology"},{"issue":"10","key":"744_CR51","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0149-2918(00)83065-9","volume":"22","author":"LC Guenther","year":"2000","unstructured":"Guenther LC, Poulin YP, Pariser DM (2000) A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis. Clin Ther 22(10):1225\u20131238","journal-title":"Clin Ther"},{"issue":"3","key":"744_CR52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(98)70323-8","volume":"39","author":"M Lebwohl","year":"1998","unstructured":"Lebwohl M, Yoles A, Lombardi K, Lou W (1998) Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol 39(3):447\u2013450","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"744_CR53","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archderm.1984.01650450051017","volume":"120","author":"KM Diette","year":"1984","unstructured":"Diette KM, Momtaz TK, Stern RS, Arndt KA, Parrish JA (1984) Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis. Arch Dermatol 120(9):1169\u20131173","journal-title":"Arch Dermatol"},{"issue":"1","key":"744_CR54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000018309","volume":"200","author":"CA Ramsay","year":"2000","unstructured":"Ramsay CA, Schwartz BE, Lowson D, Papp K, Bolduc A, Gilbert M (2000) Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. Dermatology 200(1):17\u201324","journal-title":"Dermatology"},{"issue":"3","key":"744_CR55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2133.2001.04074.x","volume":"144","author":"J Ring","year":"2001","unstructured":"Ring J, Kowalzick L, Christophers E, Schill WB, Schopf E, Stander M, Wolff HH, Altmeyer P (2001) Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. Br J Dermatol 144(3):495\u2013499","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.1983.01650270025011","volume":"119","author":"JW Petrozzi","year":"1983","unstructured":"Petrozzi JW (1983) Topical steroids and UV radiation in psoriasis. Arch Dermatol 119(3):207\u2013210","journal-title":"Arch Dermatol"},{"key":"744_CR57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archderm.1997.03890480034005","volume":"133","author":"TR Coven","year":"1997","unstructured":"Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG (1997) Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UVB. Arch Dermatol 133:514\u2013522","journal-title":"Arch Dermatol"},{"issue":"2","key":"744_CR58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/00015550310022916","volume":"84","author":"E Snellman","year":"2004","unstructured":"Snellman E, Klimenko T, Rantanen T (2004) Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath. Acta Derm Venereol 84(2):132\u2013137","journal-title":"Acta Derm Venereol"},{"key":"744_CR59","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0190-9622(99)70008-3","volume":"41","author":"PM Gordon","year":"1999","unstructured":"Gordon PM, Diffey BL, Matthews JNS, Farr PM (1999) A randomised comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 41:728\u2013732","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"744_CR60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0781.2000.160502.x","volume":"16","author":"V Leenutaphong","year":"2000","unstructured":"Leenutaphong V, Nimkulrat P, Sudtim S (2000) Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis. Photodermatol Photoimmunol Photomed 16(5):202\u2013206","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"744_CR61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0190-9622(03)00792-8","volume":"50","author":"M Grundmann-Kollmann","year":"2004","unstructured":"Grundmann-Kollmann M, Ludwig R, Zollner TM, Ochsendorf F, Thaci D, Boehncke WH, Krutmann J, Kaufmann R, Podda M (2004) Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. J Am Acad Dermatol 50(5):734\u2013739","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2133.1995.tb06924.x","volume":"133","author":"GA Katugampola","year":"1995","unstructured":"Katugampola GA, Rees AM, Lanigan SW (1995) Laser treatment of psoriasis. Br J Dermatol 133(6):909\u2013913","journal-title":"Br J Dermatol"},{"issue":"2","key":"744_CR63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/09546630310021947","volume":"15","author":"TS Housman","year":"2004","unstructured":"Housman TS, Pearce DJ, Feldman SR (2004) A maintenance protocol for psoriasis plaques cleared by the 308 nm excimer laser. J Dermatol Treat 15(2):94\u201397","journal-title":"J Dermatol Treat"},{"issue":"5","key":"744_CR64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1067\/mjd.2002.125075","volume":"47","author":"M Trehan","year":"2002","unstructured":"Trehan M, Taylor CR (2002) Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 47(5):701\u2013708","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR65","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1067\/mjd.2002.120454","volume":"46","author":"SR Feldman","year":"2002","unstructured":"Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, Vasily DB, Morison WL (2002) Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol 46(6):900\u2013906","journal-title":"J Am Acad Dermatol"},{"key":"744_CR66","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","volume":"291","author":"JA Parrish","year":"1974","unstructured":"Parrish JA, Fitzpatrick TB, Tannenbaum L, Pathak MA (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291:1207\u20131211","journal-title":"N Engl J Med"},{"issue":"4","key":"744_CR67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2133.1999.02766.x","volume":"140","author":"B Kirby","year":"1999","unstructured":"Kirby B, Buckley DA, Rogers S (1999) Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis. Br J Dermatol 140(4):661\u2013666","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.1995.tb02670.x","volume":"133","author":"DA Buckley","year":"1995","unstructured":"Buckley DA, Healy E, Rogers S (1995) A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis. Br J Dermatol 133(3):417\u2013422","journal-title":"Br J Dermatol"},{"key":"744_CR69","first-page":"217","volume":"10","author":"M Berg","year":"1994","unstructured":"Berg M, Ros AM (1994) Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen. Photodermatol Photoimmunol Photomed 10:217\u2013220","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"744_CR70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2230.2000.00589.x","volume":"25","author":"EJ Cooper","year":"2000","unstructured":"Cooper EJ, Herd RM, Priestley GC, Hunter JA (2000) A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol 25(2):111\u2013114","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"744_CR71","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2133.1992.tb00460.x","volume":"127","author":"P Collins","year":"1992","unstructured":"Collins P, Rogers S (1992) Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 127(4):392\u2013395","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR72","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000246849","volume":"189","author":"PG Calzavara-Pinton","year":"1994","unstructured":"Calzavara-Pinton PG, Ortel B, Honigsmann H, Zane C, De Panfilis G (1994) Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 189(3):256\u2013259","journal-title":"Dermatology"},{"issue":"6","key":"744_CR73","first-page":"401","volume":"164","author":"J Barth","year":"1978","unstructured":"Barth J, Dietz O, Heilmann S, Kadner H, Kraensel H, Meffert H, Metz D, Pinzer B, Schiller F (1978) Fotochemotherapie mit 8-methoxypsoralen und UVA bei Psoriasis vulgaris. Dermatol Monatsschr 164(6):401\u2013407","journal-title":"Dermatol Monatsschr"},{"issue":"11","key":"744_CR74","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-4362.2000.00913.x","volume":"39","author":"K Khurshid","year":"2000","unstructured":"Khurshid K, Haroon TS, Hussain I, Pal SS, Jahangir M, Zaman T (2000) Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV. Int J Dermatol 39(11):865\u2013867","journal-title":"Int J Dermatol"},{"issue":"2","key":"744_CR75","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2133.2001.04355.x","volume":"145","author":"WP Arnold","year":"2001","unstructured":"Arnold WP, van Andel P, de Hoop D, de Jong-Tieben L, Visser-van Andel M (2001) A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. Br J Dermatol 145(2):352\u2013354","journal-title":"Br J Dermatol"},{"issue":"1","key":"744_CR76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1346-8138.1988.tb03652.x","volume":"15","author":"YK Park","year":"1988","unstructured":"Park YK, Kim HJ, Koh YJ (1988) Combination of photochemotherapy (PUVA) and ultraviolet B (UVB) in the treatment of psoriasis vulgaris. J Dermatol 15(1): 68\u201371","journal-title":"J Dermatol"},{"issue":"5","key":"744_CR77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00006842-199809000-00020","volume":"60","author":"J Kabat-Zinn","year":"1998","unstructured":"Kabat-Zinn J, Wheeler E, Light T, Skillings A, Scharf MJ, Cropley TG, Hosmer D, Bernhard JD (1998) Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 60(5):625\u2013632","journal-title":"Psychosom Med"},{"key":"744_CR78","first-page":"351","volume":"3","author":"A Frappaz","year":"1993","unstructured":"Frappaz A, Thivolet J (1993) Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis. Eur J Dermatol 3:351\u2013354","journal-title":"Eur J Dermatol"},{"issue":"8114","key":"744_CR79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(79)90820-1","volume":"1","author":"S Rogers","year":"1979","unstructured":"Rogers S, Marks J, Shuster S, Briffa DV, Warin A, Greaves M (1979) Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet 1(8114):455\u2013458","journal-title":"Lancet"},{"issue":"4","key":"744_CR80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2230.1978.tb01512.x","volume":"3","author":"D Vella Briffa","year":"1978","unstructured":"Vella Briffa D, Rogers S, Greaves MW, Marks J, Shuster S, Warin AP (1978) A randomized, controlled clinical trial comparing photochemotherapy with dithranol in the initial treatment of chronic plaque psoriasis. Clin Exp Dermatol 3(4):339\u2013347","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"744_CR81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1984.tb07470.x","volume":"110","author":"S Parker","year":"1984","unstructured":"Parker S, Coburn P, Lawrence C, Marks J, Shuster S (1984) A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol 110(2):215\u2013220","journal-title":"Br J Dermatol"},{"issue":"5 Pt 1","key":"744_CR82","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0190-9622(89)70085-2","volume":"20","author":"JS Dover","year":"1989","unstructured":"Dover JS, McEvoy MT, Rosen CF, Arndt KA, Stern RS (1989) Are topical corticosteroids useful in phototherapy for psoriasis? J Am Acad Dermatol 20(5 Pt 1):748\u2013754","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"744_CR83","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archderm.1979.04010090024017","volume":"115","author":"CW Hanke","year":"1979","unstructured":"Hanke CW, Steck WD, Roenigk HH Jr (1979) Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate. Arch Dermatol 115(9):1074\u20131077","journal-title":"Arch Dermatol"},{"issue":"5 Pt 1","key":"744_CR84","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mjd.2000.107940","volume":"43","author":"JY Koo","year":"2000","unstructured":"Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, Gibson JR (2000) Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol 43(5 Pt 1):821\u2013828","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR85","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1365-2133.2003.05653.x","volume":"149","author":"SR McBride","year":"2003","unstructured":"McBride SR, Walker P, Reynolds NJ (2003) Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial. Br J Dermatol 149(6):1259\u20131265","journal-title":"Br J Dermatol"},{"issue":"1","key":"744_CR86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2340\/00015555756569","volume":"75","author":"NJ Levell","year":"1995","unstructured":"Levell NJ, Shuster S, Munro CS, Friedmann PS (1995) Remission of ordinary psoriasis following a short clearance course of cyclosporin. Acta Derm Venereol 75(1):65\u201369","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"744_CR87","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2133.1990.tb01481.x","volume":"123","author":"P Petzelbauer","year":"1990","unstructured":"Petzelbauer P, Honigsmann H, Langer K, Anegg B, Strohal R, Tanew A, Wolff K (1990) Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis. Br J Dermatol 123(5):641\u2013647","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/039463200401700321","volume":"17","author":"C Franchi","year":"2004","unstructured":"Franchi C, Cainelli G, Frigerio E, Garutti C, Altomare GF (2004) Association of cyclosporine and 311 nm UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach. Int J Immunopathol Pharmacol 17(3):401\u2013406","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"744_CR89","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0190-9622(82)70157-4","volume":"7","author":"BS Paul","year":"1982","unstructured":"Paul BS, Momtaz K, Stern RS, Arndt KA, Parrish JA (1982) Combined methotrexate\u2013ultraviolet B therapy in the treatment of psoriasis. J Am Acad Dermatol 7(6):758\u2013762","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"744_CR90","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0190-9622(82)70005-2","volume":"6","author":"WL Morison","year":"1982","unstructured":"Morison WL, Momtaz K, Parrish JA, Fitzpatrick TB (1982) Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 6(1):46\u201351","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR91","first-page":"707","volume":"43","author":"NG Caca-Biljanovska","year":"2002","unstructured":"Caca-Biljanovska NG, V\u2019Lckova-Laskoska MT (2002) Management of guttate and generalized psoriasis vulgaris: prospective randomized study. Croat Med J 43(6): 707\u2013712","journal-title":"Croat Med J"},{"key":"744_CR92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000248567","volume":"177","author":"JH Saurat","year":"1988","unstructured":"Saurat JH, Geiger JM, Amblard P, Beau J-C, Boulanger A, Claudy A et al (1988) Randomized double-blind multicenter study comparing acitretin-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatoligica 177:218\u2013224","journal-title":"Dermatoligica"},{"issue":"1","key":"744_CR93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1989.tb01406.x","volume":"121","author":"J Lauharanta","year":"1989","unstructured":"Lauharanta J, Geiger JM (1989) A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol 121(1):107\u2013112","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR94","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/0001555559241244","volume":"59","author":"CE Orfanos","year":"1979","unstructured":"Orfanos CE, Steigleder GK, Pullmann H, Bloch PH (1979) Oral retinoid and UVB radiation: a new, alternative treatment for psoriasis on an out-patient basis. Acta Derm Venereol 59(3):241\u2013244","journal-title":"Acta Derm Venereol"},{"issue":"5 Pt 1","key":"744_CR95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0190-9622(98)70214-2","volume":"38","author":"P Calzavara-Pinton","year":"1998","unstructured":"Calzavara-Pinton P (1998) Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination. J Am Acad Dermatol 38(5 Pt 1):687\u2013690","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"744_CR96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.139.3.325","volume":"139","author":"T Markham","year":"2003","unstructured":"Markham T, Rogers S, Collins P (2003) Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 139(3):325\u2013328","journal-title":"Arch Dermatol"},{"issue":"1","key":"744_CR97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0625.1992.tb00071.x","volume":"1","author":"P Calzavara-Pinton","year":"1992","unstructured":"Calzavara-Pinton P, Ortel B, Carlino A, Honigsmann H, De Panfilis G (1992) A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis. Exp Dermatol 1(1):46\u201351","journal-title":"Exp Dermatol"},{"key":"744_CR98","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0140-6736(81)92137-1","volume":"11","author":"T Henseler","year":"1981","unstructured":"Henseler T, Wolff K, H\u00f6nigsmann H, Christophers E (1981) Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA Study: a cooperative study among 18 European centres. Lancet 11:853\u2013857","journal-title":"Lancet"},{"issue":"2","key":"744_CR99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/09546630410023322","volume":"15","author":"H Torras","year":"2004","unstructured":"Torras H, Aliaga A, Lopez-Estebaranz JL, Hernandez I, Gardeazabal J, Quintanilla E, Mascaro JM (2004) A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris. J Dermatol Treat 15(2):98\u2013103","journal-title":"J Dermatol Treat"},{"issue":"6","key":"744_CR100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1992.01680160143028","volume":"128","author":"SM Hacker","year":"1992","unstructured":"Hacker SM, Rasmussen JE (1992) The effect of flash lamp-pulsed dye laser on psoriasis. Arch Dermatol 128(6):853\u2013855","journal-title":"Arch Dermatol"},{"issue":"23","key":"744_CR101","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1001\/jama.290.23.3073","volume":"290","author":"KB Gordon","year":"2003","unstructured":"Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A (2003) Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 290(23):3073\u20133080","journal-title":"JAMA"},{"issue":"21","key":"744_CR102","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa030002","volume":"349","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D (2003) A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 349(21):2004\u20132013","journal-title":"N Engl J Med"},{"issue":"3 Pt 1","key":"744_CR103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2004.09.029","volume":"52","author":"CL Leonardi","year":"2005","unstructured":"Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB (2005) Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol 52(3 Pt 1):425\u2013433","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"744_CR104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archderm.141.1.31","volume":"141","author":"A Menter","year":"2005","unstructured":"Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W (2005) Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis. Arch Dermatol 141(1):31\u201338","journal-title":"Arch Dermatol"},{"issue":"5","key":"744_CR105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1067\/mjd.2001.117850","volume":"45","author":"K Papp","year":"2001","unstructured":"Papp K, Bissonnette R, Kr\u00fcger JG, Carey W, Gratton D, Gulliver WP, Lui H (2001) The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody. J Am Acad Dermatol 45(5):665\u2013674","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"744_CR106","first-page":"614","volume":"3","author":"AB Gottlieb","year":"2004","unstructured":"Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL (2004) Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. J Drugs Dermatol 3(6):614\u2013624","journal-title":"J Drugs Dermatol"},{"issue":"12","key":"744_CR107","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archderm.139.12.1627","volume":"139","author":"AB Gottlieb","year":"2003","unstructured":"Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, Gaspari AA, Ling M, Weinstein GD, Nayak A, Gordon KB, Zitnik R (2003) A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol 139(12):1627\u20131632; discussion 1632","journal-title":"Arch Dermatol"},{"issue":"21","key":"744_CR108","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"CL Leonardi","year":"2003","unstructured":"Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349(21):2014\u20132022","journal-title":"N Engl J Med"},{"issue":"1","key":"744_CR109","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2133.2005.06306.x","volume":"152","author":"A Costanzo","year":"2005","unstructured":"Costanzo A, Mazzotta A, Papoutsaki M, Nistico S, Chimenti S (2005) Safety and efficacy study on etanercept in patients with plaque psoriasis. Br J Dermatol 152(1):187\u2013189","journal-title":"Br J Dermatol"},{"issue":"8","key":"744_CR110","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/ard.2004.032268","volume":"64","author":"C Antoni","year":"2005","unstructured":"Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A (2005) Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64(8):1150\u20131157","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"744_CR111","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","volume":"51","author":"AB Gottlieb","year":"2004","unstructured":"Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, Bala M, Marano CW, Menter A (2004) Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 51(4):534\u2013542","journal-title":"J Am Acad Dermatol"},{"issue":"9271","key":"744_CR112","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","volume":"357","author":"U Chaudhari","year":"2001","unstructured":"Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB (2001) Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357(9271):1842\u20131847","journal-title":"Lancet"},{"issue":"6","key":"744_CR113","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mjd.2002.120472","volume":"46","author":"RE Schopf","year":"2002","unstructured":"Schopf RE, Aust H, Knop J (2002) Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab. J Am Acad Dermatol 46(6):886\u2013891","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"744_CR114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2133.1998.02319.x","volume":"139","author":"J Koo","year":"1998","unstructured":"Koo J (1998) A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group. Br J Dermatol 139(1):88\u201395","journal-title":"Br J Dermatol"},{"issue":"4","key":"744_CR115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000066425","volume":"205","author":"D Thaci","year":"2002","unstructured":"Thaci D, Brautigam M, Kaufmann R, Weidinger G, Paul C, Christophers E (2002) Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study. Dermatology 205(4):383\u2013388","journal-title":"Dermatology"},{"issue":"1","key":"744_CR116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","volume":"32","author":"G Mahrle","year":"1995","unstructured":"Mahrle G, Schulze HG, F\u00e4rber L, Weidinger G, Steigleder GK (1995) Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail and joint involvement. J Am Acad Dermatol 32(1):78\u201388","journal-title":"J Am Acad Dermatol"},{"key":"744_CR117","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1056\/NEJM199101313240501","volume":"324","author":"CN Ellis","year":"1991","unstructured":"Ellis CN, Fradin MS, Messana JM, Brown MD, Siegel MT, Howland Hartley A (1991) Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 324:277\u2013284","journal-title":"N Engl J Med"},{"key":"744_CR118","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/j.1552-4604.1995.tb04131.x","volume":"35","author":"C Elder","year":"1995","unstructured":"Elder C, Moore M, Chang CT, Jin J, Charnick S, Nedelman J, Cohen A, Guzzo C, Lowe N, Simpson K (1995) Efficacy and pharmacokinetics of two formulations of cyclosporine in patients with psoriasis. J Clin Pharmacol 35:865\u2013875","journal-title":"J Clin Pharmacol"},{"key":"744_CR119","first-page":"186","volume":"40","author":"R Engst","year":"1989","unstructured":"Engst R, Huber J (1989) Ergebnisse einer Cyclosporin-behandlung bei schwerer, chronischer Psoriasis vulgaris. Hautarzt 40:186\u2013189","journal-title":"Hautarzt"},{"key":"744_CR120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2133.1994.tb02935.x","volume":"130","author":"C Laburte","year":"1994","unstructured":"Laburte C, Grossman R, Abi-Rached J, Abeywickrama KM, Dubertret L (1994) Efficacy and safety of oral cyclosporine A (CYA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol 130:366\u2013375","journal-title":"Br J Dermatol"},{"key":"744_CR121","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555577137141","volume":"77","author":"H Meffert","year":"1997","unstructured":"Meffert H, Braeutigam M, Faerber L, Weidinger G (1997) Low-dose (1,25mg\/kg) cyclosporine A: treatment of psoriasis and investigation of the influence on lipid profile. Acta Derm Venereol Suppl 77:137\u2013141","journal-title":"Acta Derm Venereol Suppl"},{"issue":"Suppl 1","key":"744_CR122","first-page":"8","volume":"187","author":"AF Finzi","year":"1993","unstructured":"Finzi AF, Mozzanica N, Pigatto PD, Cattaneo A, Ippolito F (1993) Cyclosporine versus etretinate: Italian multicentre comparative trial in severe psoriasis. Dermatology 187(Suppl 1):8\u201318","journal-title":"Dermatology"},{"issue":"7","key":"744_CR123","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","volume":"349","author":"VM Heydendael","year":"2003","unstructured":"Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, Bossuyt PM, Bos JD, de Rie MA (2003) Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 349(7):658\u2013665","journal-title":"N Engl J Med"},{"issue":"3","key":"744_CR124","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2133.2001.04376.x","volume":"145","author":"S Reitamo","year":"2001","unstructured":"Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE (2001) Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 145(3):438\u2013445","journal-title":"Br J Dermatol"},{"issue":"1","key":"744_CR125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0190-9622(94)70138-5","volume":"31","author":"RM Grossman","year":"1994","unstructured":"Grossman RM, Thivolet J, Claudy A, Souteyrand P, Guilhou JJ, Thomas P, Amblard P, Belaich S, de Belilovsky C, de la Brassinne M et al (1994) A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study. J Am Acad Dermatol 31(1):68\u201374","journal-title":"J Am Acad Dermatol"},{"key":"744_CR126","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0190-9622(89)70154-7","volume":"21","author":"AF Finzi","year":"1989","unstructured":"Finzi AF, Mozzanica N, Cattaneo A, Chiappino G, Pigatto PD (1989) Effectiveness of cyclosporine treatment in severe psoriasis: A clinical and immunologic study. J Am Acad Dermatol 21:91\u201397","journal-title":"J Am Acad Dermatol"},{"key":"744_CR127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1989.tb01402.x","volume":"121","author":"E Higgins","year":"1989","unstructured":"Higgins E, Munro C, Marks J, Friedmann PS, Shuster S (1989) Relapse rates in moderately severe chronic psoriasis treated with cyclosporine A. Br J Dermatol 121:71\u201374","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2133.2003.05153.x","volume":"148","author":"NH Litjens","year":"2003","unstructured":"Litjens NH, Nibbering PH, Barrois AJ, Zomerdijk TP, Van Den Oudenrijn AC, Noz KC, Rademaker M, Van De Meide PH, Van Dissel JT, Thio B (2003) Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines. Br J Dermatol 148(3):444\u2013451","journal-title":"Br J Dermatol"},{"issue":"6","key":"744_CR129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0190-9622(94)70121-0","volume":"30","author":"PJ Altmeyer","year":"1994","unstructured":"Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G, Barth J, Rietzschel I, Joshi R (1994) Antipsoriatic effect of fumaric acid derivatives. Results of a multicentre double-blind study in 100 patients. J Am Acad Dermatol 30(6):977\u2013981","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"744_CR130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000063148","volume":"205","author":"H Gollnick","year":"2002","unstructured":"Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J (2002) Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 205(1):46\u201353","journal-title":"Dermatology"},{"issue":"5 Pt 1","key":"744_CR131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0190-9622(08)80228-9","volume":"27","author":"DN Kolbach","year":"1992","unstructured":"Kolbach DN, Nieboer C (1992) Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment. J Am Acad Dermatol 27(5 Pt 1):769\u2013771","journal-title":"J Am Acad Dermatol"},{"key":"744_CR132","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(08)80766-9","volume":"22","author":"WM Nugteren-Huying","year":"1990","unstructured":"Nugteren-Huying WM, Schroeff JGvd, Hermans J, Suurmond D (1990) Fumaric acid therapy for psoriasis: a randomized, double-blind, placeFumaric acid therapy for psoriasis: a randomized, double-bo-controlled study. J Am Acad Dermatol 22:311\u2013312","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"744_CR133","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s001050050401","volume":"47","author":"P Altmeyer","year":"1996","unstructured":"Altmeyer P, Hartwig R, Matthes U (1996) Das Wirkungs-und Sicherheitsprofil von Fumars\u00e4ureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris. Eine Untersuchung an 83 Patienten. Hautarzt 47(3):190\u2013196","journal-title":"Hautarzt"},{"issue":"5","key":"744_CR134","first-page":"279","volume":"38","author":"W Bayard","year":"1987","unstructured":"Bayard W, Hunziker T, Krebs A, Speiser P, Joshi R (1987) Peroral long-term treatment of psoriasis using fumaric acid derivative. Hautarzt 38(5):279\u2013285","journal-title":"Hautarzt"},{"issue":"1","key":"744_CR135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09546630310019346","volume":"15","author":"I Carboni","year":"2004","unstructured":"Carboni I, De Felice C, De Simoni I, Soda R, Chimenti S (2004) Fumaric acid esters in the treatment of psoriasis: an Italian experience. J Dermatol Treat 15(1):23\u201326","journal-title":"J Dermatol Treat"},{"issue":"3","key":"744_CR136","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2133.1998.02124.x","volume":"138","author":"U Mrowietz","year":"1998","unstructured":"Mrowietz U, Christophers E, Altmeyer P (1998) Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Br J Dermatol 138(3):456\u2013460","journal-title":"Br J Dermatol"},{"issue":"3","key":"744_CR137","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","volume":"38","author":"HH Roenigk Jr","year":"1998","unstructured":"Roenigk HH Jr, Auerbach R, Maibach H, Weinstein G, Lebwohl M (1998) Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 38(3):478\u2013485","journal-title":"J Am Acad Dermatol"},{"key":"744_CR138","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.1971.04000130035004","volume":"103","author":"GD Weinstein","year":"1971","unstructured":"Weinstein GD, Frost P (1971) Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol 103:33\u201338","journal-title":"Arch Dermatol"},{"key":"744_CR139","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000252574","volume":"140","author":"A Nyfors","year":"1970","unstructured":"Nyfors A, Brodthagen H (1970) Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy. Dermatologica 140:345\u2013355","journal-title":"Dermatologica"},{"issue":"1","key":"744_CR140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2133.1998.02030.x","volume":"138","author":"PC van de Kerkhof","year":"1998","unstructured":"van de Kerkhof PC, Cambazard F, Hutchinson PE, Haneke E, Wong E, Souteyrand P, Damstra RJ, Combemale P, Neumann MH, Chalmers RJ, Olsen L, Revuz J (1998) The effect of addition of calcipotriol ointment (50\u00a0micrograms\/g) to acitretin therapy in psoriasis. Br J Dermatol 138(1):84\u201389","journal-title":"Br J Dermatol"},{"issue":"1","key":"744_CR141","first-page":"35","volume":"69","author":"K Kragballe","year":"1989","unstructured":"Kragballe K, Jansen CT, Geiger JM, Bjerke JR, Falk ES, Gip L, Hjorth N, Lauharanta J, Mork NJ, Reunala T et al (1989) A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study Acta Derm Venereol 69(1):35\u201340","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"744_CR142","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(89)70138-9","volume":"20","author":"AK Gupta","year":"1989","unstructured":"Gupta AK, Goldfarb MT, Ellis CN, Voorhees JJ (1989) Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol 20(6):1088\u20131093","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"744_CR143","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/archderm.139.4.436","volume":"139","author":"CS Carlin","year":"2003","unstructured":"Carlin CS, Callis KP, Krueger GG (2003) Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol 139(4):436\u2013442","journal-title":"Arch Dermatol"},{"issue":"3","key":"744_CR144","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1468-3083.1997.tb00509.x","volume":"9","author":"S Halevy","year":"1997","unstructured":"Halevy S, Giryes H, Friger M, Sukenik H (1997) Dead sea bath salt for the treatment of psoriasis vulgaris: a double- blind controlled study. J Eur Acad Dermatol Venereol 9(3):237\u2013242","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"744_CR145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00007611-197811000-00009","volume":"71","author":"DB Robertson","year":"1978","unstructured":"Robertson DB, McCarty JR, Jarratt M (1978) Treatment of psoriasis with 8-methoxypsoralen and sunlight. South Med J 71(11):1345\u20131349","journal-title":"South Med J"},{"issue":"2","key":"744_CR146","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/1523-1747.ep12319272","volume":"109","author":"ABJ Fleischer","year":"1997","unstructured":"Fleischer ABJ, Clark AR, Rapp SR, Reboussin DM, Feldman SR (1997) Commercial tanning bed treatment is an effective psoriasis treatment:results from an uncontrolled clinical trial. J Invest Dermatol 109(2):170\u2013174","journal-title":"J Invest Dermatol"},{"issue":"3","key":"744_CR147","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2133.2002.04622.x","volume":"146","author":"DG Fortune","year":"2002","unstructured":"Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE (2002) A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 146(3):458\u2013465","journal-title":"Br J Dermatol"},{"issue":"4","key":"744_CR148","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000012336","volume":"68","author":"F Tausk","year":"1999","unstructured":"Tausk F, Whitmore SE (1999) A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother Psychosom 68(4):221\u2013225","journal-title":"Psychother Psychosom"},{"key":"744_CR149","first-page":"S1","volume":"2","author":"A Nast","year":"2006","unstructured":"Nast A, Kopp I, Augustin M), Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B (2006) S3-Leitlinie zur Therapie der Psoriasis vulgaris. JDDG Suppl 2:S1\u2013S126","journal-title":"JDDG Suppl"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-007-0744-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0744-y.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T05:36:49Z","timestamp":1707889009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-007-0744-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,12]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1007\/s00403-007-0744-y","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,12]]},"assertion":[{"value":"13 February 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}